Review: taking Zantac 150 and Allegra d 24 hour together


Summary

Drug interactions are reported among people who take Zantac 150 and Allegra d 24 hour together. This review analyzes the effectiveness and drug interactions between Zantac 150 and Allegra d 24 hour. It is created by eHealthMe based on reports of 207 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Zantac 150 and Allegra d 24 hour >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Zantac 150

Zantac 150 has active ingredients of ranitidine. It is often used in indigestion. (latest outcomes from Zantac 150 3,880 users)

Allegra D 24 Hour

Allegra d 24 hour has active ingredients of fexofenadine hydrochloride; pseudoephedrine. It is often used in hypersensitivity. (latest outcomes from Allegra d 24 hour 1,367 users)

On Jul, 20, 2016

207 people who take Zantac 150, Allegra D 24 Hour are studied.


Number of reports submitted per year:

Zantac 150 and Allegra d 24 hour drug interactions.

Drug effectiveness over time:

Zantac 150:
  • < 1 month: 0.0% - (0 of 3 people)
  • 1 - 6 months: 0.0% - (0 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 66.0% - (2 of 3 people)
  • 2 - 5 years: 100.0% - (2 of 2 people)
  • 5 - 10 years: 0.0% - (0 of 2 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Allegra D 24 Hour:
  • < 1 month: 0.0% - (0 of 3 people)
  • 1 - 6 months: 50.0% - (1 of 2 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 100.0% - (3 of 3 people)
  • 2 - 5 years: 0.0% - (0 of 2 people)
  • 5 - 10 years: 0.0% - (0 of 2 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Zantac 150:
  • female: 57.0% - (4 of 7 people)
  • male: 0.0% - (0 of 5 people)
Allegra D 24 Hour:
  • female: 50.0% - (4 of 8 people)
  • male: 20.0% - (1 of 5 people)

Drug effectiveness by age:

Zantac 150:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 50.0% - (1 of 2 people)
  • 40-49: 0.0% - (0 of 3 people)
  • 50-59: 100.0% - (2 of 2 people)
  • 60+: 20.0% - (1 of 5 people)
Allegra D 24 Hour:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 66.0% - (2 of 3 people)
  • 40-49: 0.0% - (0 of 3 people)
  • 50-59: 100.0% - (2 of 2 people)
  • 60+: 20.0% - (1 of 5 people)

Most common drug interactions over time *:

< 1 month:
  • pulmonary embolism
  • cold sweat
  • nausea
  • palpitations
  • shock
  • decreased appetite
  • deep vein thrombosis
  • fatigue
  • hives
  • night sweats
1 - 6 months:
  • duodenal ulcer perforation
  • interstitial lung disease
  • neutropenia
  • pneumonitis
  • respiratory failure
  • bacteraemia
  • pneumonia
  • urticaria contact
  • diarrhoea
  • fatigue
6 - 12 months:
  • convulsion
  • shock
1 - 2 years:
  • carbohydrate craving
  • heat cramps
  • itching scar
  • joint sprain
  • petechiae
  • short-term memory loss
  • skin injury
  • skin spots - aging
  • fatigue
  • neuropathic pain
2 - 5 years:
  • abdominal discomfort
  • abdominal pain upper
  • anaemia
  • decreased appetite
  • diarrhoea
  • flatulence
  • intestinal obstruction
  • pouchitis
  • weight decreased
  • hives
5 - 10 years:
  • cholecystitis chronic
  • cholelithiasis
  • gallbladder disorder
  • stress
  • urination - excessive volume
  • bone loss
  • heart attack
  • irregular heartbeat
  • prostate cancer metastatic
  • reflux laryngitis
10+ years:
  • abdominal abscess
  • aneurysm ruptured
  • bronchial haemorrhage
  • sepsis
  • splenic haemorrhage
not specified:
  • asthenia
  • hypoaesthesia
  • weight decreased
  • pain
  • malaise
  • carpal tunnel syndrome
  • tendonitis
  • vomiting
  • nausea
  • pneumonia

Most common drug interactions by gender *:

female:
  • weight decreased
  • hypoaesthesia
  • asthenia
  • carpal tunnel syndrome
  • tendonitis
  • anorexia
  • dermatomyositis
  • fibromyalgia
  • laryngitis
  • nausea
male:
  • pneumonia
  • pain
  • asthenia
  • constipation
  • malaise
  • cough
  • disease progression
  • anxiety
  • fatigue
  • muscular weakness

Most common drug interactions by age *:

2-9:
  • anaphylactic reaction
  • angioedema
  • hypotension
  • respiratory distress
  • stridor
  • viral infection
10-19:
  • cholelithiasis
  • abdominal pain
  • abdominal pain upper
  • back pain
  • biliary colic
  • cholecystitis chronic
  • deformity
  • disability
  • gallbladder disorder
  • hepatitis
20-29:
  • cholecystitis chronic
  • gallbladder disorder
  • abdominal pain
  • nausea
  • vomiting
  • biliary dyskinesia
  • cholecystitis acute
  • cholelithiasis
  • stress
  • asthma
30-39:
  • dehydration
  • fanconi syndrome
  • anaemia
  • completed suicide
  • febrile neutropenia
  • haemolytic anaemia
  • blood pressure increased
  • cardio-respiratory arrest
  • cholelithiasis
  • metrorrhagia
40-49:
  • decreased appetite
  • weight decreased
  • abdominal discomfort
  • ascites
  • diarrhoea
  • haemoglobin decreased
  • ileus
  • intestinal fistula
  • abdominal pain upper
  • anaemia
50-59:
  • duodenal ulcer perforation
  • hypoaesthesia
  • interstitial lung disease
  • malaise
  • respiratory failure
  • abdominal pain upper
  • agitation
  • bacteraemia
  • carbohydrate craving
  • cytomegalovirus test positive
60+:
  • pneumonia
  • cough
  • nausea
  • pain
  • constipation
  • depressed level of consciousness
  • fatigue
  • malaise
  • shock
  • asthenia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Zantac 150 and Allegra d 24 hour?

Can you answer these questions?

More questions for: Zantac 150, Allegra d 24 hour

You may be interested in these reviews

More reviews for: Zantac 150, Allegra d 24 hour

On eHealthMe, Zantac 150 (ranitidine) is often used to treat indigestion. Allegra d 24 hour (fexofenadine hydrochloride; pseudoephedrine) is often used to treat hypersensitivity. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.